echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Express | 100% preventive effectiveness, Pfizer's new crown vaccine stimulates a strong immune response in adolescents

    Express | 100% preventive effectiveness, Pfizer's new crown vaccine stimulates a strong immune response in adolescents

    • Last Update: 2021-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
    75em;box-sizing:border-box ;overflow-wrap:break-word ;'>


    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
    75em;box-sizing:border-box ;overflow-wrap:break-word ;'> Today, Pfizer and BioNTech jointly announced that the new crown vaccine BNT162b2 jointly developed by the two parties has shown 100% efficacy and a strong antibody immune response in a phase 3 clinical trial conducted in adolescents aged 12-15 .
    The two companies plan to submit these data to the US FDA and other regulatory agencies around the world, hoping to initiate vaccination for this group of young people before the start of the new school year.

    Today, Pfizer and BioNTech jointly announced that the new crown vaccine BNT162b2 jointly developed by the two parties has shown 100% efficacy and a strong antibody immune response in a phase 3 clinical trial conducted in adolescents aged 12-15 .
    The two companies plan to submit these data to the US FDA and other regulatory agencies around the world, hoping to initiate vaccination for this group of young people before the start of the new school year.
    The new crown vaccine BNT162b2 demonstrated 100% efficacy and a strong antibody immune response in a phase 3 clinical trial conducted in adolescents aged 12-15544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
    75em;box-sizing:border-box ;overflow-wrap:break-word ;'>

    544px;white-space:normal;background-color:#FFFFFF;text-align:center;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.


    75em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
    75em;box-sizing:border-box ;overflow-wrap:break-word ;'>BNT162b2 is a new coronavirus vaccine based on mRNA technology.
    Not only does it show up to 95% preventive efficacy in clinical trials conducted in adults and the elderly, but the protective effect produced by vaccination in the weixin.
    qq.
    com/s?__biz=MzAwMDA5NTIxNQ==&mid=2650003098&idx=4&sn=58cf1b3f89bfcc88f5315d3b38f51f6a&scene=21#wechat_redirect" textvalue="" tab="innerlink" data-linktype="2" style="margin:0px;padding:0px;color:#576B95;text-decoration-line:none;-webkit-tap-highlight-color:rgba(0, 0, 0, 0);cursor:pointer;max-width:100%;box-sizing:border-box ;overflow-wrap:break-word ;">real world is also over 90%.


    544px;white-space:normal;background-color:#FFFFFF;line-height:1.
    75em;text-align:center;box-sizing:border-box ;overflow-wrap:break-word ;'>Image source: 123RF



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.